A case report of 131I therapy for Graves' disease patient with hemiagenesis

Xuehui Liu1, Jianping Zhang1, Zhaowei Meng2

  • 1Department of Nuclear Medicine, Third Central Hospital of Tianjin, Tianjin Institute of Hepatobiliary Disease, Tianjin Key Laboratory of Artificial Cell, Artificial Cell Engineering Technology Research Center of Public Health Ministry.

Medicine
|March 1, 2019
PubMed

Related Concept Videos